Convatec Group PLC (LON:CTEC) Stock Has Consensus Target Price of GBX 305.44

Shares of Convatec Group PLC (LON:CTEC) have been assigned an average recommendation of “Moderate Buy” from the nine research firms that are presently covering the firm, Marketbeat reports. One investment analyst has rated the stock with a hold recommendation and eight have given a buy recommendation to the company. The average 12 month price target among brokers that have issued ratings on the stock in the last year is GBX 305.44.

A number of research firms have recently weighed in on CTEC. Peel Hunt reiterated an “add” rating and set a GBX 270 target price on shares of Convatec Group in a research report on Tuesday, August 4th. Jefferies Financial Group reaffirmed a “buy” rating and issued a GBX 300 price target on shares of Convatec Group in a research note on Wednesday, August 5th. Royal Bank Of Canada reaffirmed an “outperform” rating and set a GBX 315 price objective on shares of Convatec Group in a research report on Monday, August 3rd. Berenberg Bank decreased their target price on shares of Convatec Group from GBX 340 to GBX 335 and set a “buy” rating on the stock in a report on Friday, September 11th. Finally, Deutsche Bank Aktiengesellschaft restated a “buy” rating and issued a GBX 315 target price on shares of Convatec Group in a research report on Wednesday, August 5th.

Insider Buying and Selling

In other news, insider Jens Viebke acquired 24,400 shares of the firm’s stock in a transaction that occurred on Tuesday, October 13th. The shares were acquired at an average cost of GBX 230 per share, with a total value of £56,120. Also, insider Tobias Hestler acquired 50,000 shares of the stock in a transaction on Thursday, August 6th. The shares were purchased at an average price of GBX 226 per share, with a total value of £113,000. Company insiders own 0.98% of the company’s stock.

Convatec Group Price Performance

Convatec Group stock opened at GBX 244.80 on Friday. The stock’s fifty day moving average price is GBX 224.30 and its two-hundred day moving average price is GBX 218.63. Convatec Group has a one year low of GBX 193 and a one year high of GBX 259.30. The company has a debt-to-equity ratio of 121.83, a current ratio of 1.93 and a quick ratio of 0.96. The firm has a market cap of £4.69 billion, a PE ratio of 39.48, a price-to-earnings-growth ratio of 0.93 and a beta of 0.77.

About Convatec Group

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, and bladder cancer.